Table 1 Baseline characteristics between postoperative AF and Non-AF after on-pump CABG
Variables | Non-AF (n = 1452) | AF (n = 600) | Global cohort (n = 1437) | P |
|---|---|---|---|---|
Demographics | ||||
 Sex | 0.286 | |||
  Male | 1029 (70.868%) | 189 (31.500%) | 1440 (70.175%) |  |
  Female | 423 (29.132%) | 411 (68.500%) | 612 (29.825%) |  |
 Age(years) | 64.000 (57.000, 69.000) | 64.000 (57.000, 68.000) | 62.749 ± 8.567 | 0.449 |
  BMI(kg/m2) | 25.520 (23.438, 27.736) | 25.535 (23.765, 27.757) | 25.723 ± 3.185 | 0.307 |
 History of smoking | 0.680 | |||
  No | 883 (60.813%) | 359 (59.833%) | 1242 (60.526%) |  |
  Yes | 569 (39.187%) | 241 (40.167%) | 810 (39.474%) |  |
 History of PCI | 0.213 | |||
  No | 1171 (80.647%) | 498 (83.000%) | 1669 (81.335%) |  |
  Yes | 281 (19.353%) | 102 (17.000%) | 383 (18.665%) |  |
Comorbidities | ||||
 Diabetes mellitus | 0.614 | |||
  No | 903 (62.190%) | 366 (61.000%) | 1269 (61.842%) |  |
  Yes | 549 (37.810%) | 234 (39.000%) | 783 (38.158%) |  |
 Hypertension | 0.332 | |||
  No | 427 (29.408%) | 187 (31.167%) | 614 (29.922%) |  |
  Grade 1 | 86 (5.923%) | 24 (4.000%) | 110 (5.361%) |  |
  Grade 2 | 308 (21.212%) | 130 (21.667%) | 438 (21.345%) |  |
  Grade 3 | 631 (43.457%) | 259 (43.167%) | 890 (43.372%) |  |
Preoperative drug use | ||||
 β-Receptor blocker | 0.504 | |||
  No | 359 (24.725%) | 140 (23.333%) | 499 (24.318%) |  |
  Yes | 1093 (75.275%) | 460 (76.667%) | 1553 (75.682%) |  |
 Statin | 0.031 | |||
  No | 117 (8.058%) | 32 (5.333%) | 149 (7.261%) |  |
  Yes | 1335 (91.942%) | 568 (94.667%) | 1903 (92.739%) |  |
 ACEI/ARB | 0.782 | |||
  No | 994 (68.457%) | 407 (67.833%) | 1401 (68.275%) |  |
  Yes | 458 (31.543%) | 193 (32.167%) | 651 (31.725%) |  |
Examination | ||||
 White blood count(× 109/L) | 6.300 (5.400, 7.500) | 6.400 (5.300, 7.500) | 6.535 ± 1.675 | 0.716 |
 Red blood count(× 1012/L) | 4.400 (4.000, 4.800) | 4.400 (4.100, 4.700) | 4.419 ± 0.998 | 0.575 |
 NLR | 2.089 (1.568, 2.825) | 2.095 (1.531, 2.720) | 2.397 ± 1.502 | 0.594 |
 Hemoglobin (g/ dl) | 135.000 (123.000, 147.000) | 136.000 (124.000, 147.000) | 135.021 ± 18.501 | 0.497 |
 Platelet count(× 109/L) | 214.000 (180.000, 253.000) | 219.500 (181.750, 262.000) | 220.306 ± 58.281 | 0.041 |
 A/G | 1.615 (1.448, 1.800) | 1.600 (1.448, 1.792) | 1.629 ± 0.292 | 0.837 |
 AST/ALT | 0.904 (0.694, 1.176) | 0.895 (0.694, 1.154) | 1.039 ± 0.802 | 0.614 |
 Creatinine (mg/ dl) | 69.000 (59.000, 81.000) | 69.000 (58.000, 80.000) | 72.245 ± 33.236 | 0.331 |
 LDL(mmol/L) | 2.545 (1.970,3.300) | 2.610 (1.980,3.340) | 2.748 ± 0.991 | 0.236 |
 HDL(mmol/L) | 0.990 (0.850,1.150) | 0.990 (0.840,1.140) | 1.022 ± 0.621 | 0.538 |
 LDL/HDL | 2.630 (2.030,3.350) | 2.670 (2.138,3.360) | 2.766 ± 0.996 | 0.115 |
 Left main coronary artery stenosis | ||||
  No | 1067 (73.994%) | 441 (74.118%) | 1508 (74.030%) |  |
  Yes | 375 (26.006%) | 154 (25.882%) | 529 (25.970%) |  |
 EF (%) | 61.000 (55.000, 65.000) | 61.500 (56.000, 66.000) | 59.387 ± 9.491 | 0.138 |
 LVEDD(mm) | 48.000 (45.000, 51.000) | 48.000 (46.000, 52.000) | 48.841 ± 5.514 | 0.008 |
 LAD(mm) | 37.000 (35.000, 40.000) | 38.000 (35.000, 41.000) | 38.058 ± 5.307 | 0.006 |